InvestorsHub Logo
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: mcd2inga post# 14189

Tuesday, 06/10/2008 2:29:50 PM

Tuesday, June 10, 2008 2:29:50 PM

Post# of 30387
Dr Moro is expressing to shareholders that he has recently gained a significant amount knowledge on the intracacies of Recaf and NOW he is finally ready to show and challenge any other institution, research center, or scientist on the merits of his discovery.
Prior to the new patents and his commitment to perfect and reach optimal results, he wasn't ready to make such a bold statement. He has recently developed a "recipe" for a lack of a better word, that can show and duplicate our results. They will be questioned because they are in another league when compared to today's acceptable standards by doctors and insurance companies. It is unphathomable to the scientific community that there can actually be one "universal" marker and that is the challenge Dr Moro is facing. In the past, developing commercial ways to utilize the marker, collecting the data, and focusing on getting repeatable accurate results was the challenge.
Recently he stated that he is now pleased and comfortable with all the testing and now he will focus on commercialization. Things are much different from the last meeting. The hard part is over and when he has the opportunity in front of a live audience he will challenge them and allow them to test Recaf for themselves. He would have never done this prior to the new ELISA test, but he needed the patents in place to protect his discovery.
There will be much more interest when he presents the newest data and IMO he will finally get thru to the audience that this is not a fluke and they can now test it themselves. It will be exciting times from that day forward. It is like a beautiful painting. You wouldn't want to show it until you are satisfied with the last stroke of the brush.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.